Home › Categories › Government & Policy› Rebate Walls

Rebate Walls.pdf

RebateWall_F_web.pdf

🔗 Source: pacificresearch.org

📊 Size: 1.38 MB

📄 Pages: 43 pages

⬇️ Downloads: 267

Summary

The current drug rebate system fails patients by increasing costs, with rebates growing at double-digit rates and patient costs skyrocketing. The "rebate wall" practice, where rebates are tied to volume targets, blocks patient access to lower-priced medicines, causing prices to remain high and imposing large costs on patients. Competition between drugs, including brand name, generic, and biosimilar products, generates significant healthcare savings, with studies showing discounts of up to 69% for follow-on branded drugs and 61.4% for generic medicines. Eliminating rebate wall practices could reclaim tens of thousands of dollars in potential savings for patients, with estimated lost savings ranging from $1,300 to $44,600 per year for patients with employer-sponsored health insurance, Medicare, or infused drugs.

Download File

Description

The current drug rebate system fails patients by increasing costs, with rebates growing at double-digit rates and patient costs skyrocketing.

Technical Information

File Format: PDF
File Size: 1.38 MB
Pages: 43
Language: EN
Total Downloads: 267
Last Updated: 1 week ago

Document Overview

This PDF document about Rebate Walls provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Rebate Walls.